ARIXTRA has a broad range of
FDA-approved indications
ARIXTRA is approved for the treatment and prophylaxis of venous thromboembolism (VTE). Learn more about approved indications for ARIXTRA below:
- Treatment of deep vein thrombosis (DVT)
- Treatment of pulmonary embolism (PE)
- VTE prophylaxis after major orthopedic surgery*
- Extended VTE prophylaxis after hip fracture surgery
- VTE prophylaxis after abdominal surgery
*Knee replacement, hip replacement and hip fracture surgery.
